Therapy News and Research

RSS

IGDRASOL to present updates on Cynviloq at AACR annual meeting

Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its development of Cynviloq (IG-001) at the annual meeting of the American Association for Cancer Research in Washington, DC (April 6th to 10th).

1 Apr 2013

Looking good helps women cancer patients feel better, gives more confidence to cope with disease

A year ago, Colleen Williams was into the natural look. She seldom bothered to put on makeup and she let her long, wavy, brown hair flow free. Cancer treatment changed that. These days, when she feels well enough to go to work, Williams wears her "cute hat" to cover her newly-balding head and takes a little extra time in the morning to pencil in her thinning brows and apply concealer to make her skin look a little less gray.

30 Mar 2013

Study: Obstructive sleep apnea increases rates of ADHD-like behavioral problems in children

A new study found that obstructive sleep apnea, a common form of sleep-disordered breathing (SDB), is associated with increased rates of ADHD-like behavioral problems in children as well as other adaptive and learning problems.

30 Mar 2013

New research shows surgical menopause increases cognitive decline and dementia

Women who abruptly and prematurely lose estrogen from surgical menopause have a two-fold increase in cognitive decline and dementia.

30 Mar 2013

Study shows hormonal therapy increases risk of breast cancer

The study Dr. Chlebowski authored reported that estrogen plus progestin use is linked with increased breast cancer incidence. In addition, it said the prognosis is similar for both users and nonusers of combined hormone therapy, suggesting that mortality from breast cancer may be higher for hormone therapy users as well.

30 Mar 2013

Jacob Landis to make cross-country bicycle tour to raise funds for people with hearing loss

A 24-year-old hearing-impaired baseball fan from Annapolis, Md., hopes to raise $1 million to help others facing hearing loss, so they too can experience in what he calls his "miracle," the cochlear implant performed at The Johns Hopkins Hospital in 1999 that restored much of his hearing when he was 10 years old.

30 Mar 2013

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

The U.S. Food and Drug Administration today approved Invokana (canaglifozin) tablets, used with diet and exercise, to improve glycemic control in adults with type 2 diabetes.

30 Mar 2013

BioMed Central launches new journal BMC Sports Science, Medicine and Rehabilitation

Open access publisher BioMed Central is proud to announce the launch of BMC Sports Science, Medicine and Rehabilitation, another addition to the BMC-series portfolio.

30 Mar 2013

CDC to portray impact of COPD in COPD Foundation's anti-smoking ad campaign

The COPD Foundation announces today that the Centers for Disease Control and Prevention will, for the first time, depict the impact of Chronic Obstructive Pulmonary Disease in its national ad campaign, Tips From Former Smokers.

30 Mar 2013

Studies examine existing opportunity to improve interventions, outcomes of TBI in older adults

Considerable opportunity exists to improve interventions and outcomes of traumatic brain injury in older adults, according to three studies published in the recent online issue of NeuroRehabilitation by researchers from the Icahn School of Medicine at Mount Sinai.

30 Mar 2013

Cytori receives patent for methods of treating renal diseases using ADRCs

Cytori Therapeutics received US Patent No. 8,404,229 (the '229 patent) for methods of treating renal diseases using adipose-derived regenerative cells (ADRCs).

30 Mar 2013

Correctional policies discourage released inmates from seeking methadone therapy, researchers say

Methadone treatment for opioid dependence remains widely unavailable behind bars in the United States, and many inmates are forced to discontinue this evidence-based therapy, which lessens painful withdrawal symptoms.

30 Mar 2013

Wilderness therapy programs are less dangerous than football games

Adolescents participating in wilderness and adventure therapy programs are at significantly less risk of injury than those playing football and are three times less likely to visit the emergency room for an injury than if they were at home, a new study by University of New Hampshire researchers finds.

29 Mar 2013

MD Anderson researchers named Fellows to new AACR academy

Five researchers and leaders from The University of Texas MD Anderson Cancer Center have been named Fellows to a new academy launched by the world's oldest and largest organization dedicated to cancer research, the American Association for Cancer Research.

29 Mar 2013

Drug costs and pricing issues touch hospitals, independent pharmacies

NPR reports on how one hospital made what is termed an "unusual decision" -- it chose to not stock a new drug because it was very costly.

29 Mar 2013

Different metrics should be used in different settings to measure ARV program success

Studies show "the profound impact of antiretroviral-therapy coverage at a population level" -- how wider coverage can increase life expectancy and reduce the risk of HIV infection.

29 Mar 2013

Study: Hormone-therapy-related breast cancer cells can be attacked by cancer therapies

More than 100 women per day die from breast cancer in the United States. The odds of developing breast cancer increase for women taking hormone replacement therapy to avoid the effects of menopause.

28 Mar 2013

First Edition: March 28, 2013

Today's headlines include various stories about the health law's implementation at both the federal and state level.

28 Mar 2013

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.

28 Mar 2013

Neurological researchers study promising new treatment for deadly brain tumors

A promising new treatment for deadly brain tumors taken orally with minimal side effects is being studied by neurological researchers at Rush University Medical Center, Chicago.

28 Mar 2013

Therapy News and Research

IGDRASOL to present updates on Cynviloq at AACR annual meeting

Looking good helps women cancer patients feel better, gives more confidence to cope with disease

Study: Obstructive sleep apnea increases rates of ADHD-like behavioral problems in children

New research shows surgical menopause increases cognitive decline and dementia

Study shows hormonal therapy increases risk of breast cancer

Jacob Landis to make cross-country bicycle tour to raise funds for people with hearing loss

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

BioMed Central launches new journal BMC Sports Science, Medicine and Rehabilitation

CDC to portray impact of COPD in COPD Foundation's anti-smoking ad campaign

Studies examine existing opportunity to improve interventions, outcomes of TBI in older adults

Cytori receives patent for methods of treating renal diseases using ADRCs

Correctional policies discourage released inmates from seeking methadone therapy, researchers say

Wilderness therapy programs are less dangerous than football games

MD Anderson researchers named Fellows to new AACR academy

Drug costs and pricing issues touch hospitals, independent pharmacies

Different metrics should be used in different settings to measure ARV program success

Study: Hormone-therapy-related breast cancer cells can be attacked by cancer therapies

First Edition: March 28, 2013

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Neurological researchers study promising new treatment for deadly brain tumors

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News